Augmedix Inc
NASDAQ:AUGX
Relative Value
The Relative Value of one AUGX stock under the Base Case scenario is 3.45 USD. Compared to the current market price of 3.18 USD, Augmedix Inc is Undervalued by 8%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
AUGX Competitors Multiples
Augmedix Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Augmedix Inc
NASDAQ:AUGX
|
154.6m USD | 3.4 | -8.1 | -7 | -6.6 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.1B USD | 13.6 | 61 | 60.7 | 65.3 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | ||
JP |
M3 Inc
TSE:2413
|
1.3T JPY | 5.5 | 27.8 | 14.7 | 16.6 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7.2B USD | 11.5 | -340.3 | -180 | -167.3 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
10.5B AUD | 71.6 | 150.1 | 103.1 | 103.1 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.7B USD | 10 | 34.1 | 23 | 24.5 | ||
SE |
Sectra AB
STO:SECT B
|
40.4B SEK | 24.7 | 95.2 | -62.6 | -62.6 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.4B USD | 1.7 | -23.7 | 27.7 | 295.4 | ||
US |
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 11.7 | -324 | 264.4 | 4 233.4 |